IONIS PHARMACEUTICAL

IONS
Delayed Quote. Delayed  - 09/27 04:00:00 pm
35.87USD -0.91%

Turn to zoom
Prev.36.2000
Open36.1100
High36.4515
Low35.7000
Volume790 414
Latest news
09/16
09/15
09/09
09/06
Chart IONIS PHARMACEUTICALS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralBearish
Resistance37,847,345,8
Spread/Res.-5,2%-24%-22%
Spread/Supp.-0,61%3,9%3,9%
Support36,134,534,5
Financials
Sales 2021 618 M - -
Net income 2021 -258 M - -
Net Debt 2021 123 M - -
P/E ratio 2021 -19,5x
Yield 2021 -
Capitalization 5 063 M 5 063 M -
EV / Sales 2021 8,39x
EV / Sales 2022 8,18x
Nbr of Employees 757
Free-Float 95,0%
Company
Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company, using its drug discovery platform, has developed a pipeline of drugs for patients with unmet medical needs. The Company's segments include Ionis Core and Akcea...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-11-10 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 35,87 $
Average target price 55,07 $
Spread / Average Target 53,5%